Gelber R H, Brennan P J, Hunter S W, Munn M W, Monson J M, Murray L P, Siu P, Tsang M, Engleman E G, Mohagheghpour N
Kuzell Institute for Arthritis and Infectious Diseases, San Francisco, California 94115.
Infect Immun. 1990 Mar;58(3):711-8. doi: 10.1128/iai.58.3.711-718.1990.
Model vaccines against leprosy bacilli have consisted of nonvirulent, live, attenuated Mycobacterium bovis BCG and irradiated, heat-killed, or autoclaved intact M. leprae. We report that immunization with various cell wall fractions of M. leprae, progressively depleted of lipids, carbohydrates, and soluble proteins, as well as a partially purified protein(s) derived from a pellet fraction of sonicated M. leprae, conferred significant protection against subsequent infection with live leprosy bacilli. Moreover, lymphocytes from regional lymph nodes and spleens of mice immunized with these M. leprae-derived subunits responded by proliferation when stimulated with M. leprae in vitro. Our results provide the first evidence that vaccination with M. leprae-derived fractions protects mice against leprosy bacilli.
针对麻风杆菌的模型疫苗包括无毒的、活的、减毒牛分枝杆菌卡介苗以及经辐射、加热灭活或高压灭菌的完整麻风杆菌。我们报告称,用麻风杆菌的各种细胞壁组分进行免疫接种,这些组分的脂质、碳水化合物和可溶性蛋白质逐渐减少,以及从超声处理的麻风杆菌沉淀组分中获得的部分纯化蛋白质,可对随后的活麻风杆菌感染提供显著保护。此外,用这些麻风杆菌衍生亚单位免疫的小鼠区域淋巴结和脾脏中的淋巴细胞,在体外受到麻风杆菌刺激时会通过增殖作出反应。我们的结果提供了首个证据,即接种麻风杆菌衍生组分可保护小鼠免受麻风杆菌感染。